Revisiting: “Comparison of intravascular ultrasound versus angiography-guided drug-eluting stent implantation: a meta-analysis of one randomised trial and ten observational studies involving 19,619 patients”
EuroIntervention 2013;9:891-892 published online ahead of print April 2013. DOI: 10.4244/EIJV9I7A148
Yao-Jun Zhang1,2, MD, PhD; Hector M. Garcia-Garcia2, MD, PhD; Vasim Farooq2, MBChB, MRCP; Christos V. Bourantas2, MD, PhD; Patrick W. Serruys2, MD, PhD; Shao-Liang Chen1*, MD, PhD
1. Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China; 2. Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
Recently, we have published the manuscript entitled “Comparison of intravascular ultrasound versus angiography-guided drug-eluting stent (DES) implantation: a meta-analysis of one randomised trial and ten observational studies involving 19,619 patients”. Two additional important studies (namely, the ADAPT-DES and the RESET), comparing IVUS- and angiography-guided DES implantation have recently been reported1,2. In addition, the two-year clinical follow-up of the randomised AVIO trial was published recently3. Therefore, our meta-analysis needs to be updated.
The ADAPT-DES (Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents) trial was a prospective multicentre registry study that enrolled approximately 11,000 patients1. The outcomes, after IVUS-guided percutaneous coronary intervention (PCI), ...